References
- Matsui W, Wang Q, Barber J P, Brennan S, Smith B D, Borrello I, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008; 68: 190–197
- Yata K, Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 2004; 18: 1891–1897
- Kapoor P, Greipp P T, Morice W G, Rajkumar S V, Witzig T E, Greipp P R. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol 2008; 141: 135–148
- Zipori D. The stem state: mesenchymal plasticity as a paradigm. Curr Stem Cell Res Ther 2006; 1: 95–102
- Wu C, Alman B A. Side population cells in human cancers. Cancer Lett 2008
- Loh Y SC, Mo S, Brown R D, et al. Presence of Hoechst low side populations in multiple myeloma. Leuk Lymphoma 2008; 49: 1813–1816